RepliCel Historical Income Statement

Stocks . Canada . 
Stock . RepliCel Life Sciences
RP Stock  CAD 0.01  0.00  0.00%   
Historical analysis of RepliCel Life income statement accounts such as Total Other Income Expense Net of 1.1 M, Selling General Administrative of 1.5 M, Selling And Marketing Expenses of 472 K or Gross Profit of 374.9 K can show how well RepliCel Life Sciences performed in making a profits. Evaluating RepliCel Life income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of RepliCel Life's future profits or losses.
Cash Flow   Balance Sheet     Income Statement
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Financial Statement Analysis is much more than just reviewing and examining RepliCel Life Sciences latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether RepliCel Life Sciences is a good buy for the upcoming year.
  
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About RepliCel Income Statement Analysis

RepliCel Life Sciences Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to RepliCel Life shareholders. The income statement also shows RepliCel investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Balance Sheet
Statement
Details
Cash Flow
Statement
Details
Financial
Indicators
Details
Valuation
Indicators
Details

RepliCel Life Income Statement Chart

At this time, RepliCel Life's Interest Expense is fairly stable compared to the past year. Other Operating Expenses is likely to climb to about 2.7 M in 2024, whereas Operating Income is likely to drop (1.5 M) in 2024.
Other Operating Expenses  Total Operating Expenses  Selling General Administrative  Selling And Marketing Expenses  
Add Fundamental

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of RepliCel Life Sciences. It is also known as RepliCel Life overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Total Operating Expenses

The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.
Most accounts from RepliCel Life's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into RepliCel Life Sciences current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
At this time, RepliCel Life's Interest Expense is fairly stable compared to the past year. Other Operating Expenses is likely to climb to about 2.7 M in 2024, whereas Operating Income is likely to drop (1.5 M) in 2024.

RepliCel Life income statement Correlations

Depreciation And Amortization
Interest Expense
Other Operating Expenses
Operating Income
Ebit
Ebitda
Total Operating Expenses
Income Before Tax
Total Other Income Expense Net
Net Income
Income Tax Expense
Selling General Administrative
Selling And Marketing Expenses
Gross Profit
Research Development
Cost Of Revenue
Total Revenue
Net Income From Continuing Ops
Reconciled Depreciation
Depreciation And Amortization
-0.590.27-0.26-0.27-0.270.27-0.23-0.01-0.23-0.20.37-0.50.280.080.510.59-0.040.9
Interest Expense
-0.59-0.410.350.360.36-0.410.430.280.450.11-0.540.08-0.24-0.16-0.14-0.30.3-0.62
Other Operating Expenses
0.27-0.41-0.84-0.83-0.831.0-0.79-0.04-0.81-0.250.930.460.210.74-0.55-0.16-0.640.57
Operating Income
-0.260.35-0.840.990.99-0.840.960.160.960.49-0.81-0.310.07-0.580.350.30.74-0.47
Ebit
-0.270.36-0.830.991.0-0.830.930.10.930.55-0.81-0.31-0.01-0.530.350.220.67-0.49
Ebitda
-0.270.36-0.830.991.0-0.830.930.10.930.55-0.81-0.31-0.01-0.530.350.220.67-0.49
Total Operating Expenses
0.27-0.411.0-0.84-0.83-0.83-0.79-0.04-0.81-0.250.930.460.210.74-0.55-0.16-0.640.57
Income Before Tax
-0.230.43-0.790.960.930.93-0.790.381.00.4-0.74-0.320.14-0.630.330.350.84-0.42
Total Other Income Expense Net
-0.010.28-0.040.160.10.1-0.040.380.390.210.03-0.030.2-0.3-0.050.150.510.02
Net Income
-0.230.45-0.810.960.930.93-0.811.00.390.39-0.76-0.340.13-0.660.340.350.85-0.43
Income Tax Expense
-0.20.11-0.250.490.550.55-0.250.40.210.39-0.280.03-0.280.030.02-0.250.09-0.24
Selling General Administrative
0.37-0.540.93-0.81-0.81-0.810.93-0.740.03-0.76-0.280.380.30.47-0.5-0.05-0.510.64
Selling And Marketing Expenses
-0.50.080.46-0.31-0.31-0.310.46-0.32-0.03-0.340.030.380.020.47-0.84-0.53-0.39-0.24
Gross Profit
0.28-0.240.210.07-0.01-0.010.210.140.20.13-0.280.30.02-0.19-0.230.780.520.33
Research Development
0.08-0.160.74-0.58-0.53-0.530.74-0.63-0.3-0.660.030.470.47-0.19-0.34-0.4-0.780.3
Cost Of Revenue
0.51-0.14-0.550.350.350.35-0.550.33-0.050.340.02-0.5-0.84-0.23-0.340.430.250.24
Total Revenue
0.59-0.3-0.160.30.220.22-0.160.350.150.35-0.25-0.05-0.530.78-0.40.430.650.46
Net Income From Continuing Ops
-0.040.3-0.640.740.670.67-0.640.840.510.850.09-0.51-0.390.52-0.780.250.65-0.23
Reconciled Depreciation
0.9-0.620.57-0.47-0.49-0.490.57-0.420.02-0.43-0.240.64-0.240.330.30.240.46-0.23
Click cells to compare fundamentals

RepliCel Life Account Relationship Matchups

High Positive Relationship

Total Operating Expenses
+ 1.0
Other Operating Expenses
Ebitda
+ 1.0
Ebit
Net Income
+ 1.0
Income Before Tax
Ebit
+ 0.99
Operating Income
Ebitda
+ 0.99
Operating Income
Income Before Tax
+ 0.96
Operating Income

High Negative Relationship

Cost Of Revenue
- 0.84
Selling And Marketing Expenses
Total Operating Expenses
- 0.84
Operating Income
Operating Income
- 0.84
Other Operating Expenses
Total Operating Expenses
- 0.83
Ebitda
Total Operating Expenses
- 0.83
Ebit
Ebitda
- 0.83
Other Operating Expenses

RepliCel Life income statement Accounts

201920202021202220232024 (projected)
Depreciation And Amortization2.2K1.6K1.1K839.01.5K1.4K
Interest Expense141.4K176.1K5.5K6.7K149.1K156.6K
Other Operating Expenses3.3M1.7M2.7M1.7M1.7M2.7M
Operating Income(2.9M)(1.1M)(3.2M)(191.4K)(1.4M)(1.5M)
Ebit(2.9M)(1.1M)(3.2M)(191.4K)(1.4M)(1.5M)
Ebitda(2.9M)(1.1M)(3.2M)(190.6K)(1.4M)(1.5M)
Total Operating Expenses3.3M1.7M2.7M1.7M1.7M2.6M
Income Before Tax(3.0M)(1.6M)(4.1M)(743.2K)(311.7K)(327.3K)
Total Other Income Expense Net(77.3K)(252.4K)(1.8M)656.1K1.1M1.1M
Net Income(3.0M)(1.6M)(4.1M)(743.2K)(311.7K)(327.3K)
Income Tax Expense44.0K183.5K(867.9K)1.2M(1.0)(1.05)
Selling General Administrative1.1M884.7K1.5M1.1M1.2M1.5M
Research Development2.2M819.4K1.1M624.0K526.4K500.1K
Net Income From Continuing Ops(3.0M)(1.6M)(4.1M)(743.2K)(69.3K)(72.8K)
Net Income Applicable To Common Shares(2.8M)(3.0M)(1.6M)(4.1M)(4.7M)(4.9M)
Net Interest Income(92.0K)(175.7K)69.0(6.7K)(1.1K)(1.1K)
Interest Income92.0K358.069.043.0725.0688.75
Reconciled Depreciation2.2K1.6K1.1K839.01.4K1.6K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for RepliCel Stock Analysis

When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY